Moleculin Biotech Inc (MBRX)
2.45
0.00 (0.00%)
USD |
NASDAQ |
Nov 04, 16:00
2.43
-0.02
(-0.82%)
After-Hours: 20:00
Moleculin Biotech Market Cap: 6.969M for Nov. 4, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 04, 2024 | 6.969M |
| November 01, 2024 | 6.969M |
| October 31, 2024 | 7.396M |
| October 30, 2024 | 7.225M |
| October 29, 2024 | 7.453M |
| October 28, 2024 | 7.453M |
| October 25, 2024 | 7.325M |
| October 24, 2024 | 7.225M |
| October 23, 2024 | 7.254M |
| October 22, 2024 | 7.254M |
| October 21, 2024 | 7.595M |
| October 18, 2024 | 7.353M |
| October 17, 2024 | 6.713M |
| October 16, 2024 | 6.884M |
| October 15, 2024 | 6.628M |
| October 14, 2024 | 6.742M |
| October 11, 2024 | 6.941M |
| October 10, 2024 | 6.912M |
| October 09, 2024 | 7.254M |
| October 08, 2024 | 7.111M |
| October 07, 2024 | 7.140M |
| October 04, 2024 | 6.713M |
| October 03, 2024 | 6.998M |
| October 02, 2024 | 7.168M |
| October 01, 2024 | 7.936M |
| Date | Value |
|---|---|
| September 30, 2024 | 8.078M |
| September 27, 2024 | 7.822M |
| September 26, 2024 | 6.941M |
| September 25, 2024 | 6.855M |
| September 24, 2024 | 7.652M |
| September 23, 2024 | 7.709M |
| September 20, 2024 | 6.742M |
| September 19, 2024 | 6.998M |
| September 18, 2024 | 7.026M |
| September 17, 2024 | 6.656M |
| September 16, 2024 | 6.855M |
| September 13, 2024 | 6.912M |
| September 12, 2024 | 6.912M |
| September 11, 2024 | 6.827M |
| September 10, 2024 | 6.742M |
| September 09, 2024 | 6.713M |
| September 06, 2024 | 6.827M |
| September 05, 2024 | 7.083M |
| September 04, 2024 | 6.855M |
| September 03, 2024 | 7.026M |
| August 30, 2024 | 7.254M |
| August 29, 2024 | 7.225M |
| August 28, 2024 | 7.140M |
| August 27, 2024 | 7.026M |
| August 26, 2024 | 7.254M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
5.622M
Minimum
Aug 08 2024
156.31M
Maximum
Feb 10 2021
44.49M
Average
40.96M
Median
Market Cap Benchmarks
| Agilent Technologies Inc | 40.13B |
| Seelos Therapeutics Inc | 0.4011M |
| Cara Therapeutics Inc | 15.93M |
| Citius Pharmaceuticals Inc | 62.42M |
| NovaBay Pharmaceuticals Inc | 3.694M |
Market Cap Related Metrics
| Price to Book Value | 0.3904 |
| Price | 2.45 |
| Earnings Yield | -486.2% |